-
I-Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |Uchungechunge lwe-amino acid |Fmoc-3-(2-Naphthyl)-L-alanine |CAS:112883-43-9 |I-C28H23NO4
-
I-Fmoc-Trp(Boc)-OH 143824-78-6
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |I-Fmoc-Trp(Boc)-OH |CAS:143824-78-6 |I-C31H30N2O6
-
I-Fmoc-L-Leucine 35661-60-0
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |Uchungechunge lwe-amino acid |I-Fmoc-L-Leucine |I-CAS:35661-60-0 |I-C21H23NO4
-
I-Fmoc-D-leucine 114360-54-2
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |Uchungechunge lwe-amino acid |I-Fmoc-D-leucine |I-CAS:114360-54-2 |I-C21H23NO4
-
I-N6--[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |I-CAS:1202003-49-3 |I-C27H34N2O6
-
O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine |I-CAS:1013883-02-7 |I-C31H34N2O7
-
I-Hippuric acid 495-69-2
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Immunology |I-Peptide synthesis |I-Hippuric acid |CAS:495-69-2 |C9H9NO3
-
I-Valsartan 137862-53-4
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Ama-Chemical Reagents |Chemical Raw materials |Imboni yezemithi Lesisemkhatsini |Inhliziyo |Ukwelashwa kwe-hypertension |I-Valsartan Intermediates |Valsartan |CAS:137862-53-4 |I-C24H29N5O3
-
I-L-Valine methyl ester hydrochloride 6306-52-1
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Ama-Chemical Reagents |Chemical Raw materials |Imboni yezemithi Lesisemkhatsini |Inhliziyo |I-Valsartan Intermediates |I-L-Valine methyl ester hydrochloride |CAS:6306-52-1 |I-C6H13NO2.HCl
-
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Ama-Chemical Reagents |Chemical Raw materials |Imboni yezemithi Lesisemkhatsini |Inhliziyo |Ukwelashwa kwe-hypertension |I-Valsartan Intermediates |N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride |CAS:482577-59-3 |I-C20H22N2O2.HCl
-
I-Valsartan methyl ester 137863-17-3
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Ama-Chemical Reagents |Chemical Raw materials |Imboni yezemithi Lesisemkhatsini |Inhliziyo |Ukwelashwa kwe-hypertension |I-Valsartan Intermediates |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine methyl ester |CAS:137863-17-3 |I-C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |I-Pharmaceutical Intermediates Reagents |Izifo ezithathelwanayo |Dermatological |Luliconazole Abaphakathi |(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethano |CAS:126534-31-4 |I-C8H7Cl3O